| Active substance | Peptide |
|---|---|
| Release form | Vial |
| Water Retention | Minimal |
| Hepatotoxicity | None reported |
| Lab Test | Growth hormone levels can be monitored |
| Also known as | N/A |
| Blood pressure | No significant impact |
| Trade name | Not marketed under a specific trade name |
| Storage conditions | Store in a cool, dry place away from light |
| Chemical name | Ipamorelin |
| Formula | C38H49N9O5 |
| Substance class | Growth hormone secretagogue |
| Main action | Stimulates the release of growth hormone |
| Half-life | Approximately 2 hours |
| Dosage (medical) | Typically, 200-300 mcg three times a day |
| Dosage (sports) | 200-300 mcg two to three times a day |
| Effects | Increased lean muscle mass, reduced body fat, improved recovery |
| Side effects | Headaches, light-headedness, soreness at injection site |
| Use in sports | Commonly used for muscle building and performance enhancement |
| Active ingredient, mg | 2 |
| Manufacturer | Driada Medical |
| Packing | Vial |
Reviews
There are no reviews yet.